EXTRACELLULAR MATRIX ABNORMALITIES IN CORNEAL EDEMA

角膜水肿的细胞外基质异常

基本信息

  • 批准号:
    6459478
  • 负责人:
  • 金额:
    $ 18.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1995
  • 资助国家:
    美国
  • 起止时间:
    1995-08-01 至 2002-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from applicant's abstract): Pseudophakic (PBK) and aphakic (ABK) bullous keratopathy is the most common indication for corneal transplantation. The investigators have showed that in PBK/ABK corneas, there is an increased expression and deposition of specific isoforms of an extracellular matrix protein, tenascin-C (TN-C), that is not expressed in normal corneas. TN-C can affect cell adhesion, migration and proliferation that are important in wound healing and tissue remodeling. They have also shown that PBK/ABK corneas have a corresponding increase in the expression of TN-C integrin receptors and certain growth factors/cytokines, which could induce TN-C expression. The following hypotheses are proposed: (1) that PBK/ABK corneas present an ongoing "injury-response cycle" where the entire cornea stays in a continuous state of remodeling, (2) growth factors and/or cytokines play an important role in this cycle, and (3) the expression and deposition of TN-C affects the adhesive, migratory, proliferative and functional properties of corneal cells. Understanding these facets could lead to future therapeutic interventions. While TN-C, growth factors and cytokines are thought to play a significant role in PBK/ABK pathogenesis, other as yet unidentified abnormalities are probably also involved. Therefore, powerful new micro-sensitive techniques have been adapted for differential screening of genes from individual corneas. The hypothesis is that with these techniques, abnormalities in the expression of other genes important for PBK/ABK pathogenesis will be identified. There are three specific aims: (1) to determine the function of TN-C isoforms in PBK/ABK corneas by growing corneal cells on various isoforms of TN-C and determine rates of cell adhesion, migration, proliferation and function; (2) to determine the influence of growth factors and cytokines upon the expression of TN-C and TN-C binding integrins by: (a) identifying the abnormal growth factors/cytokines in PBK/ABK corneas, (b) determining the effects that these factors and dexamethasone have on the expression of TN-C and its binding integrins in corneal cells in vitro, and (c) determining if various isoforms of TN-C can affect the expression of TN-C binding integrins in vitro; and (3) to examine the differential gene expression in normal and PBK/ABK corneas and identify unique gene expression patterns by: (a) screening cellular mRNAs in normal vs. PBK/ABK corneas and cell layers using differential display, nucleic acid array and subtraction libraries; (b) determining if differentially-expressed genes are specific for PBK/ABK; and (c) determining whether altered gene expression in PBK/ABK is reflected at the protein level.
描述(改编自申请人摘要):人工晶状体(PBK)和 无晶状体(ABK)大泡性角膜病变是角膜炎最常见的适应症。 移植 研究人员已经表明,在PBK/ABK角膜中, 存在增加的表达和沉积的特异性同种型, 细胞外基质蛋白,腱生蛋白-C(TN-C),不表达于 正常的角膜 TN-C可影响细胞的粘附、迁移和增殖 对伤口愈合和组织重塑很重要 他们还 显示PBK/ABK角膜具有相应的表达增加, TN-C整合素受体和某些生长因子/细胞因子, 诱导TN-C表达。 提出了以下假设:(1) PBK/ABK角膜呈现出一个持续的“损伤-反应循环”,其中整个 角膜保持在重塑的连续状态,(2)生长因子和/或 细胞因子在此循环中起重要作用,和(3)表达和 TN-C的沉积影响粘附性、迁移性、增殖性和 角膜细胞的功能特性。 了解这些方面可以 导致未来的治疗干预。 虽然TN-C、生长因子和细胞因子被认为在肿瘤的发生发展中起着重要作用, 在PBK/ABK发病机制中的作用,其他尚未确定的异常是 可能也参与其中。 因此,强大的新型微敏感技术 已被改造用于个体基因的差异筛选, 角膜 假设是,通过这些技术, 对PBK/ABK发病机制重要的其他基因的表达将是 鉴定 具体目标有三:(1)确定功能 通过在各种不同的培养条件下培养角膜细胞, TN-C亚型,并测定细胞粘附,迁移, 增殖和功能;(2)确定生长因子的影响 和细胞因子,通过以下方式表达TN-C和TN-C结合整联蛋白: (a)鉴定PBK/ABK角膜中的异常生长因子/细胞因子, (b)确定这些因素和地塞米松对 TN-C及其结合整合素在体外角膜细胞中的表达,和 (c)确定TN-C的各种同种型是否可以影响 TN-C结合整合素的体外实验;(3)检测差异基因 在正常和PBK/ABK角膜中的表达,并鉴定独特的基因表达 模式:(a)筛选正常与PBK/ABK角膜中的细胞mRNA, 使用差异显示、核酸阵列和减法的细胞层 库;(B)确定差异表达的基因是否具有特异性 (c)确定在PBK/ABK中改变的基因表达是否 反映在蛋白质水平上。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARIA C KENNEY其他文献

MARIA C KENNEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARIA C KENNEY', 18)}}的其他基金

AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    $ 18.35万
  • 项目类别:
Protective Effects of Humanin on AMD Mitochondria
护脑素对 AMD 线粒体的保护作用
  • 批准号:
    10165719
  • 财政年份:
    2019
  • 资助金额:
    $ 18.35万
  • 项目类别:
EXTRACELLULAR MATRIX ABNORMALITIES IN CORNEAL EDEMA
角膜水肿的细胞外基质异常
  • 批准号:
    6524909
  • 财政年份:
    1995
  • 资助金额:
    $ 18.35万
  • 项目类别:
EXTRACELLULAR MATRIX ABNORMALITIES IN CORNEAL EDEMA
角膜水肿的细胞外基质异常
  • 批准号:
    2164988
  • 财政年份:
    1995
  • 资助金额:
    $ 18.35万
  • 项目类别:
EXTRACELLULAR MATRIX ABNORMALITIES IN CORNEAL EDEMA
角膜水肿的细胞外基质异常
  • 批准号:
    6384416
  • 财政年份:
    1995
  • 资助金额:
    $ 18.35万
  • 项目类别:
EXTRACELLULAR MATRIX ABNORMALITIES IN CORNEAL EDEMA
角膜水肿的细胞外基质异常
  • 批准号:
    2459159
  • 财政年份:
    1995
  • 资助金额:
    $ 18.35万
  • 项目类别:
EXTRACELLULAR MATRIX ABNORMALITIES IN CORNEAL EDEMA
角膜水肿的细胞外基质异常
  • 批准号:
    2164989
  • 财政年份:
    1995
  • 资助金额:
    $ 18.35万
  • 项目类别:
EXTRACELLULAR MATRIX ABNORMALITIES IN CORNEAL EDEMA
角膜水肿的细胞外基质异常
  • 批准号:
    2701409
  • 财政年份:
    1995
  • 资助金额:
    $ 18.35万
  • 项目类别:
EXTRACELLULAR MATRIX ABNORMALITIES IN CORNEAL EDEMA
角膜水肿的细胞外基质异常
  • 批准号:
    6179950
  • 财政年份:
    1995
  • 资助金额:
    $ 18.35万
  • 项目类别:
EXTRACELLULAR MATRIX ABNORMALITIES IN CORNEAL EDEMA
角膜水肿的细胞外基质异常
  • 批准号:
    2888455
  • 财政年份:
    1995
  • 资助金额:
    $ 18.35万
  • 项目类别:

相似海外基金

A novel mechanism of cell growth regulation by the intrinsically disordered protein, NPM1
内在无序蛋白 NPM1 调节细胞生长的新机制
  • 批准号:
    26440021
  • 财政年份:
    2014
  • 资助金额:
    $ 18.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study on the mechanism of cell growth regulation by ST2 and its possible anti-cancerous effect.
ST2调节细胞生长的机制及其可能的抗癌作用研究。
  • 批准号:
    25460393
  • 财政年份:
    2013
  • 资助金额:
    $ 18.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular Mechanisms for cell growth regulation by Mnk-mediated translational control
Mnk 介导的翻译控制调节细胞生长的分子机制
  • 批准号:
    24590105
  • 财政年份:
    2012
  • 资助金额:
    $ 18.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Integrating Phosphatidylcholine Metabolism with Cell Growth Regulation
将磷脂酰胆碱代谢与细胞生长调节相结合
  • 批准号:
    221878
  • 财政年份:
    2010
  • 资助金额:
    $ 18.35万
  • 项目类别:
    Operating Grants
UNDERSTANDING THE ROLES OF SMALL GTPASES IN CELL GROWTH REGULATION
了解小 GTP 酶在细胞生长调节中的作用
  • 批准号:
    7955176
  • 财政年份:
    2009
  • 资助金额:
    $ 18.35万
  • 项目类别:
Roles of the Golgi apparatus in cell growth regulation
高尔基体在细胞生长调节中的作用
  • 批准号:
    18570173
  • 财政年份:
    2006
  • 资助金额:
    $ 18.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of cell growth regulation by small G proteins
小G蛋白调节细胞生长的机制
  • 批准号:
    17014061
  • 财政年份:
    2005
  • 资助金额:
    $ 18.35万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
The role of Kaiso in cell growth regulation
Kaiso 在细胞生长调节中的作用
  • 批准号:
    302718-2004
  • 财政年份:
    2004
  • 资助金额:
    $ 18.35万
  • 项目类别:
    Postgraduate Scholarships - Master's
Bone Cell Growth Regulation by Runx2/Cbfa1
Runx2/Cbfa1 调节骨细胞生长
  • 批准号:
    6619987
  • 财政年份:
    2003
  • 资助金额:
    $ 18.35万
  • 项目类别:
Bone Cell Growth Regulation by Runx2/Cbfa1
Runx2/Cbfa1 调节骨细胞生长
  • 批准号:
    6898940
  • 财政年份:
    2003
  • 资助金额:
    $ 18.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了